Clinical Trial Update: Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis [NA]

View source ↗

Summary

This entry provides an update on a Cairo University-sponsored trial evaluating Celecoxib (Celebrex) as premedication for symptomatic irreversible pulpitis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: Cairo University | Conditions: Pulpitis | NA | Status: UNKNOWN